La Lingua Nostra La Lingua Nostra
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Offers
  • Jobs
  • Postari
  • Articles
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Shahir Shahir a adăugat un fișier Alte
    2026-03-18 13:52:13 -
    Breast Cancer Diagnostics Market Revenue Forecast and Growth Outlook 2036
    The global landscape for breast cancer diagnostics is undergoing a fundamental shift from volume-based testing to value-based precision diagnostics. According to the latest strategic analysis by Fact.MR, the market, valued at USD 5,878 million in 2025, is poised to reach USD 6,389.41 million in 2026. This trajectory is set to continue at a steady 6.9% CAGR, propelling the industry to a...
    0 Commentarii 0 Distribuiri 295 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Sophie Lane a adăugat un fișier Alte
    2026-04-02 11:58:11 -
    Breast Cancer Diagnostics Market Trends Transforming Cancer Screening
    The increasing prevalence of oncology-related conditions and the global push for early intervention are driving a transformative era in medical imaging and molecular testing. The Breast Cancer Diagnostics Market was valued at USD 4.89 billion in 2024 and is expected to reach USD 10.33 billion by 2032, growing at a robust CAGR of 12.71% during the forecast...
    0 Commentarii 0 Distribuiri 176 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Akshay Gorde a adăugat un fișier Health
    2026-04-07 12:37:32 -
    ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Outlook and Deep Study of Top Key Players Analysis By FMI
    NEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...
    0 Commentarii 0 Distribuiri 194 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 La Lingua Nostra Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne